本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 一、基本情况概述 南京高科股份有限公司（以下简称"公司"）于2020年10月28日召开的第十届董事会第五次会议审议通过 了《关于投资设立南京高科创业投资合伙企业（有限合伙）的议案》（详见公司临2020-046号公告）， 同意公司投资设立南京高科创业投资合伙企业（有限合伙）（以下简称"高科创投基金"）。2022年12月 29日，公司第十届董事会第十八次会议审议通过了《关于对南京高科创业投资合伙企业（有限合伙）增 资的议案》（详见公司临2022-051号公告），同意公司作为有限合伙人以现金形式对高科创投基金增资 50,000万元。 高科创投基金认缴出资总额为人民币100,000万元，其中南京高科新浚投资管理有限公司作为管理人和 普通合伙人认缴出资100万元；公司以及公司全资子公司南京高科新创投资有限公司、南京高科科技小 额贷款有限公司作为有限合伙人分别认缴出资50,000万元、44,910万元、4,990万元。为提升基金运作效 率，公司董事会同意授权公司董事长处理与该基金有关的 ...

Core Viewpoint - Nanjing Gaoke Co., Ltd. has announced the extension of the operational period of its venture capital partnership, Nanjing Gaoke Venture Capital Partnership (Limited Partnership), to December 2028, due to the current market environment and the fund's operational status [1][3]. Summary by Sections Basic Information Overview - The company established the Nanjing Gaoke Venture Capital Partnership in October 2020, with a total subscribed capital of RMB 100 million [2]. - The fund has made investments in 21 projects in sectors such as biomedicine and semiconductor materials, with a total investment of RMB 694 million [2]. - The fund's original term was set to expire in December 2025, but due to incomplete capital investment and ongoing projects, the term has been extended by three years [2]. Impact of Fund Extension - The extension aims to ensure stable operations of the fund and enhance overall returns, aligning with the fundamental interests of all shareholders [3]. - The company will encourage the fund manager to improve the selection of quality projects and actively manage the exit of invested projects to boost fund returns [3].